Terms: = Colorectal cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568
558 results:
1. Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistance.
Lu S; Zhao R; Han Y; Shao S; Ji Y; Zhang J; Pan H; Sun J; Feng Y
Clin Exp Med; 2024 Sep; 24(1):219. PubMed ID: 39261380
[TBL] [Abstract] [Full Text] [Related]
2. [Bioinformatic prediction and validation of cellular-mesenchymal epithelial transition(c-Met) as a target for chimeric antigen receptor T (CAR-T) cell therapy in the treatment of colorectal cancer].
Peng S; Min J; Long C; Xie Z; Zhang L; Li H; Li Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jul; 40(7):614-622. PubMed ID: 39179404
[TBL] [Abstract] [Full Text] [Related]
3. The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells.
Wang F; Bashiri Dezfouli A; Multhoff G
Mol Immunol; 2024 Oct; 174():1-10. PubMed ID: 39126837
[TBL] [Abstract] [Full Text] [Related]
4. Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results.
Parkhurst M; Goff SL; Lowery FJ; Beyer RK; Halas H; Robbins PF; Prickett TD; Gartner JJ; Sindiri S; Krishna S; Zacharakis N; Ngo L; Ray S; Bera A; Shepherd R; Levin N; Kim SP; Copeland A; Nah S; Levi S; Parikh N; Kwong MLM; Klemen ND; Yang JC; Rosenberg SA
Nat Med; 2024 Sep; 30(9):2586-2595. PubMed ID: 38992129
[TBL] [Abstract] [Full Text] [Related]
5. Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides.
Altves S; Guclu E; Yetisgin E; Bilecen K; Vural H
World J Microbiol Biotechnol; 2024 May; 40(7):204. PubMed ID: 38755413
[TBL] [Abstract] [Full Text] [Related]
6. il-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p.
Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E
J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of the safety of Levilactobacillus brevis CNCM I-5321, a probiotic candidate strain isolated from pulque with anti-proliferative activities.
Torres-Maravilla E; Boucard AS; Al Azzaz J; Gontier S; Kulakauskas S; Langella P; Bermúdez-Humarán LG
Benef Microbes; 2023 Sep; 14(4):335-348. PubMed ID: 38661393
[TBL] [Abstract] [Full Text] [Related]
8. Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.
Hatthakarnkul P; Pennel K; Alexander P; van Wyk H; Roseweir A; Inthagard J; Hay J; Andersen D; Maka N; Park J; Roxburgh C; Thuwajit C; McMillan D; Edwards J
J Pathol Clin Res; 2024 May; 10(3):e12374. PubMed ID: 38650367
[TBL] [Abstract] [Full Text] [Related]
9. Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.
Maia A; Tarannum M; Lérias JR; Piccinelli S; Borrego LM; Maeurer M; Romee R; Castillo-Martin M
Cells; 2024 Mar; 13(5):. PubMed ID: 38474415
[TBL] [Abstract] [Full Text] [Related]
10. The combination of il-2 nanoparticles and Palbociclib enhances the anti-tumor immune response for colon cancer therapy.
Wang D; Wang X; Zhang Y; Yu L; An J; Wang X; Huang Y; Han X
Front Immunol; 2024; 15():1309509. PubMed ID: 38352877
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
Amaria R; Knisely A; Vining D; Kopetz S; Overman MJ; Javle M; Antonoff MB; Tzeng CD; Wolff RA; Pant S; Lito K; Rangel K; Fellman B; Yuan Y; Lu KH; Sakellariou-Thompson D; Haymaker CL; Forget MA; Hwu P; Bernatchez C; Jazaeri AA
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38309721
[TBL] [Abstract] [Full Text] [Related]
12. Genetic association of circulating interleukins and risk of colorectal cancer: A bidirectional Mendelian randomization study.
Dong J; Jiang W; Zhang W; Hu R; Huang Z; Guo T; Du T; Jiang X
Environ Toxicol; 2024 May; 39(5):2706-2716. PubMed ID: 38240193
[TBL] [Abstract] [Full Text] [Related]
13. Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases.
Li CMY; Tomita Y; Dhakal B; Tin T; Li R; Wright JA; Vrbanac L; Woods SL; Drew P; Price T; Smith E; Maddern GJ; Fenix K
Cancer Immunol Immunother; 2024 Jan; 73(1):6. PubMed ID: 38231291
[TBL] [Abstract] [Full Text] [Related]
14. Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer.
Toffoli EC; van Vliet AA; Verheul HWM; van der Vliet HJ; Tuynman J; Spanholtz J; de Gruijl TD
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056896
[TBL] [Abstract] [Full Text] [Related]
15. Targeting regulatory T cells by E7777 enhances CD8 T-cell-mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models.
Mahdi HS; Woodall-Jappe M; Singh P; Czuczman MS
Front Immunol; 2023; 14():1268979. PubMed ID: 38022532
[TBL] [Abstract] [Full Text] [Related]
16. Cholesterol induction in CD8
Shuwen H; Yinhang W; Jing Z; Qiang Y; Yizhen J; Quan Q; Yin J; Jiang L; Xi Y
Cancer Immunol Immunother; 2023 Dec; 72(12):4441-4456. PubMed ID: 37919522
[TBL] [Abstract] [Full Text] [Related]
17. Exploring the Therapeutic Potential of Fe
Mahdavi Niyaki Z; Salehzadeh A; Peymani M; Zaefizadeh M
Biol Trace Elem Res; 2024 Jul; 202(7):3073-3085. PubMed ID: 37792268
[TBL] [Abstract] [Full Text] [Related]
18. Reigniting hope in cancer treatment: the promise and pitfalls of il-2 and il-2R targeting strategies.
Muhammad S; Fan T; Hai Y; Gao Y; He J
Mol Cancer; 2023 Jul; 22(1):121. PubMed ID: 37516849
[TBL] [Abstract] [Full Text] [Related]
19. Transformation of immunosuppressive mtKRAS tumors into immunostimulatory tumors by Nerofe and Doxorubicin.
Ohana J; Sandler U; Devary O; Devary Y
Oncotarget; 2023 Jul; 14():688-699. PubMed ID: 37395796
[TBL] [Abstract] [Full Text] [Related]
20. Mechanistic insights into the anti-tumor and anti-metastatic effects of Patrinia villosa aqueous extract in colon cancer via modulation of TGF-β R1-smad2/3-E-cadherin and FAK-RhoA-cofilin pathways.
Yang H; Yue GG; Yuen KK; Gao S; Leung PC; Wong CK; Lau CB
Phytomedicine; 2023 Aug; 117():154900. PubMed ID: 37269754
[TBL] [Abstract] [Full Text] [Related]
[Next]
